HealthDay (5/31) reports, “Prenatal exposure to topiramate, valproate, and certain duotherapies is associated with increased risks for autism spectrum disorder (ASD) and intellectual disability,” investigators concluded in a study including data “for 4,494,926 alive-born children with available mother-child identities and maternal prescription” information. The findings were published online May 31 in JAMA Neurology.
Related Links:
— “Prenatal Exposure to Certain Antiseizure Meds Linked to Autism, HealthDay, May 31, 2022